Cargando…
Hepatoprotective effect of protocatechuic acid against type 2 diabetes-induced liver injury
CONTEXT: Protocatechuic acid (PCA) has a protective effect on alcoholic liver injury, but the role of PCA in type 2 diabetes-induced liver injury is not well known. OBJECTIVES: This study explores the therapeutic effect and potential mechanism of PCA on type 2 diabetes-induced liver injury. MATERIAL...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155631/ https://www.ncbi.nlm.nih.gov/pubmed/37129023 http://dx.doi.org/10.1080/13880209.2023.2181359 |
_version_ | 1785036371260342272 |
---|---|
author | Xu, Kaixia Lu, Guang Feng, Qianjin Chen, Shuangchao Wang, Yonghui |
author_facet | Xu, Kaixia Lu, Guang Feng, Qianjin Chen, Shuangchao Wang, Yonghui |
author_sort | Xu, Kaixia |
collection | PubMed |
description | CONTEXT: Protocatechuic acid (PCA) has a protective effect on alcoholic liver injury, but the role of PCA in type 2 diabetes-induced liver injury is not well known. OBJECTIVES: This study explores the therapeutic effect and potential mechanism of PCA on type 2 diabetes-induced liver injury. MATERIALS AND METHODS: An insulin resistance/type 2 diabetic (IR/D) model was established by high-fat diet for 4 weeks + streptozotocin (35 mg/kg; i.p) in male Wistar rats pretreated with or without PCA (15 or 30 mg/kg for 6 d). RESULTS: PCA at 15 and 30 mg/kg significantly upregulated the levels of body weight (BW; 230.2, 257.8 g), high density lipids (22.68, 34.78 mg/dL), glutathione (10.24, 16.21 nmol/mg), superoxide dismutase (21.62, 29.34 U/mg), glucagon-like peptide-1, glucose transporter-4, Wnt1, and β-catenin, while downregulating those of liver weight (LW; 9.4, 6.7 g), BW/LW (4.1, 2.6%), serum glucose (165, 120 mg/dL), serum insulin (13.46, 8.67 μIU/mL), homeostatic model assessment of insulin resistance (5.48, 2.57), total cholesterol (68.52, 54.31 mg/dL), triglycerides (72.15, 59.64 mg/dL), low density lipids (42.18, 30.71), aspartate aminotransferase (54.34 and 38.68 U/L), alanine aminotransferase (42.87, 29.98 U/L), alkaline phosphatase (210.16, 126.47 U/L), malondialdehyde (16.52, 10.35), pro-inflammatory markers (tumor necrosis factor α (TNF-α (149.67, 120.33 pg/mg)) , IL-6 (89.79, 73.69 pg/mg) and IL-1β (49.67, 38.73 pg/mg)), nuclear factor kappa B (NF-κB), and interleukin-1β, and ameliorated the abnormal pathological changes in IR/D rats. DISCUSSION AND CONCLUSION: PCA mitigates the IR, lipid accumulation, oxidative stress, and inflammation in liver tissues of IR/D rats by modulating the NF-κB and Wnt1/β-catenin pathways. |
format | Online Article Text |
id | pubmed-10155631 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-101556312023-05-04 Hepatoprotective effect of protocatechuic acid against type 2 diabetes-induced liver injury Xu, Kaixia Lu, Guang Feng, Qianjin Chen, Shuangchao Wang, Yonghui Pharm Biol Research Article CONTEXT: Protocatechuic acid (PCA) has a protective effect on alcoholic liver injury, but the role of PCA in type 2 diabetes-induced liver injury is not well known. OBJECTIVES: This study explores the therapeutic effect and potential mechanism of PCA on type 2 diabetes-induced liver injury. MATERIALS AND METHODS: An insulin resistance/type 2 diabetic (IR/D) model was established by high-fat diet for 4 weeks + streptozotocin (35 mg/kg; i.p) in male Wistar rats pretreated with or without PCA (15 or 30 mg/kg for 6 d). RESULTS: PCA at 15 and 30 mg/kg significantly upregulated the levels of body weight (BW; 230.2, 257.8 g), high density lipids (22.68, 34.78 mg/dL), glutathione (10.24, 16.21 nmol/mg), superoxide dismutase (21.62, 29.34 U/mg), glucagon-like peptide-1, glucose transporter-4, Wnt1, and β-catenin, while downregulating those of liver weight (LW; 9.4, 6.7 g), BW/LW (4.1, 2.6%), serum glucose (165, 120 mg/dL), serum insulin (13.46, 8.67 μIU/mL), homeostatic model assessment of insulin resistance (5.48, 2.57), total cholesterol (68.52, 54.31 mg/dL), triglycerides (72.15, 59.64 mg/dL), low density lipids (42.18, 30.71), aspartate aminotransferase (54.34 and 38.68 U/L), alanine aminotransferase (42.87, 29.98 U/L), alkaline phosphatase (210.16, 126.47 U/L), malondialdehyde (16.52, 10.35), pro-inflammatory markers (tumor necrosis factor α (TNF-α (149.67, 120.33 pg/mg)) , IL-6 (89.79, 73.69 pg/mg) and IL-1β (49.67, 38.73 pg/mg)), nuclear factor kappa B (NF-κB), and interleukin-1β, and ameliorated the abnormal pathological changes in IR/D rats. DISCUSSION AND CONCLUSION: PCA mitigates the IR, lipid accumulation, oxidative stress, and inflammation in liver tissues of IR/D rats by modulating the NF-κB and Wnt1/β-catenin pathways. Taylor & Francis 2023-05-02 /pmc/articles/PMC10155631/ /pubmed/37129023 http://dx.doi.org/10.1080/13880209.2023.2181359 Text en © 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent. |
spellingShingle | Research Article Xu, Kaixia Lu, Guang Feng, Qianjin Chen, Shuangchao Wang, Yonghui Hepatoprotective effect of protocatechuic acid against type 2 diabetes-induced liver injury |
title | Hepatoprotective effect of protocatechuic acid against type 2 diabetes-induced liver injury |
title_full | Hepatoprotective effect of protocatechuic acid against type 2 diabetes-induced liver injury |
title_fullStr | Hepatoprotective effect of protocatechuic acid against type 2 diabetes-induced liver injury |
title_full_unstemmed | Hepatoprotective effect of protocatechuic acid against type 2 diabetes-induced liver injury |
title_short | Hepatoprotective effect of protocatechuic acid against type 2 diabetes-induced liver injury |
title_sort | hepatoprotective effect of protocatechuic acid against type 2 diabetes-induced liver injury |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10155631/ https://www.ncbi.nlm.nih.gov/pubmed/37129023 http://dx.doi.org/10.1080/13880209.2023.2181359 |
work_keys_str_mv | AT xukaixia hepatoprotectiveeffectofprotocatechuicacidagainsttype2diabetesinducedliverinjury AT luguang hepatoprotectiveeffectofprotocatechuicacidagainsttype2diabetesinducedliverinjury AT fengqianjin hepatoprotectiveeffectofprotocatechuicacidagainsttype2diabetesinducedliverinjury AT chenshuangchao hepatoprotectiveeffectofprotocatechuicacidagainsttype2diabetesinducedliverinjury AT wangyonghui hepatoprotectiveeffectofprotocatechuicacidagainsttype2diabetesinducedliverinjury |